DK0752847T3 - Ophthalmisk sammensætning med nedsat viskositet - Google Patents

Ophthalmisk sammensætning med nedsat viskositet

Info

Publication number
DK0752847T3
DK0752847T3 DK95914362T DK95914362T DK0752847T3 DK 0752847 T3 DK0752847 T3 DK 0752847T3 DK 95914362 T DK95914362 T DK 95914362T DK 95914362 T DK95914362 T DK 95914362T DK 0752847 T3 DK0752847 T3 DK 0752847T3
Authority
DK
Denmark
Prior art keywords
amount
pct
weight
viscosity
composition
Prior art date
Application number
DK95914362T
Other languages
Danish (da)
English (en)
Inventor
Kari Lehmussaari
Timo Reunamaeki
Eija Vartiainen
Olli Oksala
Sakari Alaranta
Esko Pohjala
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0752847T3 publication Critical patent/DK0752847T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95914362T 1994-03-31 1995-03-29 Ophthalmisk sammensætning med nedsat viskositet DK0752847T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401108A SE9401108D0 (sv) 1994-03-31 1994-03-31 Ophthalmic composition I
PCT/FI1995/000166 WO1995026711A1 (en) 1994-03-31 1995-03-29 Ophthalmic composition with decreased viscosity

Publications (1)

Publication Number Publication Date
DK0752847T3 true DK0752847T3 (da) 2001-10-22

Family

ID=20393511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914362T DK0752847T3 (da) 1994-03-31 1995-03-29 Ophthalmisk sammensætning med nedsat viskositet

Country Status (26)

Country Link
US (1) US5710182A (cs)
EP (1) EP0752847B1 (cs)
JP (1) JPH10503470A (cs)
KR (1) KR100365914B1 (cs)
CN (1) CN1112918C (cs)
AT (1) ATE202921T1 (cs)
AU (1) AU694497B2 (cs)
BG (1) BG63145B1 (cs)
BR (1) BR9507438A (cs)
CA (1) CA2186734A1 (cs)
CZ (1) CZ290987B6 (cs)
DE (2) DE752847T1 (cs)
DK (1) DK0752847T3 (cs)
EE (1) EE03661B1 (cs)
ES (1) ES2161874T3 (cs)
GR (1) GR3036763T3 (cs)
HU (1) HU223071B1 (cs)
MX (1) MX9603918A (cs)
NO (1) NO314434B1 (cs)
PL (1) PL179433B1 (cs)
PT (1) PT752847E (cs)
RO (1) RO115409B1 (cs)
RU (1) RU2139016C1 (cs)
SE (1) SE9401108D0 (cs)
SK (1) SK280492B6 (cs)
WO (1) WO1995026711A1 (cs)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
AU4808000A (en) 1999-04-28 2000-11-10 Situs Corporation Drug delivery system
KR100366439B1 (ko) * 2000-02-21 2003-01-09 주식회사 대웅 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물
US6852688B2 (en) 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
RU2191013C2 (ru) * 2000-10-04 2002-10-20 Федеральное унитарное предприятие "Московский эндокринный завод" Антиглаукоматозное средство
US7128928B2 (en) * 2002-02-22 2006-10-31 Pharmacia Corporation Ophthalmic formulation with novel gum composition
SI1484054T1 (sl) * 2002-02-22 2012-12-31 Santen Pharmaceutical Co. Ltd. Sistem razdeljevanja zdravil za subkonjuktivalno dajane finih zrn
CN101336887A (zh) * 2002-12-04 2009-01-07 参天制药株式会社 结膜下给药用药物组合物
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2839930C (en) * 2003-06-13 2016-07-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI347847B (en) * 2003-08-20 2011-09-01 Santen Pharmaceutical Co Ltd Drug delivery system for sub-tenon administration of fine particles
RU2278656C1 (ru) * 2004-11-29 2006-06-27 Уфимский научно-исследовательский институт глазных болезней Вискоэластик для защиты внутриглазных тканей глаза
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
RU2340327C1 (ru) * 2007-05-03 2008-12-10 Лев Давидович Раснецов Офтальмологический гель и способ его приготовления
US20110190323A1 (en) * 2008-08-28 2011-08-04 President And Fellows Of Harvard College Cortistatin analogues and syntheses thereof
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
WO2012108489A1 (ja) * 2011-02-10 2012-08-16 参天製薬株式会社 親水性薬物の薬物移行性を改善した水性組成物
US20150038557A1 (en) 2012-02-24 2015-02-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treatment of retinal degenerative diseases
EP3505521A1 (en) 2013-12-24 2019-07-03 President and Fellows of Harvard College Cortistatin analogues and syntheses and uses thereof
WO2016182932A1 (en) 2015-05-08 2016-11-17 President And Fellows Of Harvard College Cortistatin analogues, syntheses, and uses thereof
HK1248570A1 (zh) 2015-05-29 2018-10-19 西德奈克西斯公司 D2o稳定化的药物制剂
WO2017004411A1 (en) 2015-07-01 2017-01-05 President And Fellows Of Harvard College Cortistatin analogues and syntheses and uses thereof
ES2908479T3 (es) 2015-08-26 2022-04-29 Achillion Pharmaceuticals Inc Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
JP2019509997A (ja) 2016-02-17 2019-04-11 ザ チルドレンズ メディカル センター コーポレーション 神経血管形成疾患または障害の治療標的としてのｆｆａ１（ｇｐｒ４０）
WO2017197051A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Amine-linked c3-glutarimide degronimers for target protein degradation
CA3029262A1 (en) 2016-06-27 2018-01-04 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
WO2018033854A1 (en) * 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
AU2017311636B2 (en) 2016-08-19 2023-08-10 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
FI3985002T3 (fi) 2017-03-01 2025-07-30 Achillion Pharmaceuticals Inc Aryyli-, heteroaryyli- ja heterosyklisiä lääkeyhdisteitä sairauksien hoitoon
EP3970694A1 (en) * 2017-05-11 2022-03-23 Vyluma Inc. Atropine pharmaceutical compositions
CN118440096A (zh) 2017-06-20 2024-08-06 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
KR20210018199A (ko) 2018-03-26 2021-02-17 씨4 테라퓨틱스, 인코포레이티드 이카로스의 분해를 위한 세레블론 결합제
US20230022157A1 (en) 2018-08-20 2023-01-26 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
EP3846803A4 (en) 2018-09-06 2022-08-10 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
GB201904125D0 (en) * 2019-03-26 2019-05-08 Ge Healthcare Bio Sciences Ab Method for sanitization of a chromatography column
EP3953332A4 (en) 2019-04-12 2023-06-14 C4 Therapeutics, Inc. TRICYCLIC DEGRADATION PRODUCTS FROM IKAROS AND AIOLOS
US20250197403A1 (en) 2020-02-20 2025-06-19 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
BR112022017393A2 (pt) 2020-03-05 2022-10-18 C4 Therapeutics Inc Composto, composição farmacêutica, método para tratar um transtorno mediado por brd9, e, uso de um composto
WO2022066774A1 (en) 2020-09-23 2022-03-31 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders
EP4288049A4 (en) * 2021-02-04 2025-01-01 Sydnexis, Inc. OPHTHALMIC COMPOSITIONS FOR PRESBYOPIA
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
CN113786380A (zh) * 2021-09-18 2021-12-14 华北制药股份有限公司 一种硝酸毛果芸香碱眼用凝胶及其制备方法
WO2025160409A1 (en) 2024-01-26 2025-07-31 Flagship Pioneering Innovations V, Inc. Viral vectors for modulating vegf function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
RU2000790C1 (ru) * 1987-07-15 1993-10-15 Уфимский научно-исследовательский институт глазных болезней Глазна мазь
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
RU2056821C1 (ru) * 1993-02-26 1996-03-27 Межотраслевой научно-технический комплекс "Микрохирургия глаза" Глазные капли "кератоник"

Also Published As

Publication number Publication date
EE03661B1 (et) 2002-04-15
PL179433B1 (pl) 2000-09-29
HU9602691D0 (en) 1996-11-28
WO1995026711A1 (en) 1995-10-12
HU223071B1 (hu) 2004-03-01
NO314434B1 (no) 2003-03-24
SK280492B6 (sk) 2000-03-13
NO964070D0 (no) 1996-09-27
SE9401108D0 (sv) 1994-03-31
BG63145B1 (bg) 2001-05-31
ES2161874T3 (es) 2001-12-16
SK123996A3 (en) 1997-06-04
CZ286596A3 (en) 1997-04-16
BG100915A (en) 1997-07-31
ATE202921T1 (de) 2001-07-15
PL316584A1 (en) 1997-01-20
DE69521686T2 (de) 2002-04-25
EE9600120A (et) 1997-04-15
CA2186734A1 (en) 1995-10-12
CN1144477A (zh) 1997-03-05
PT752847E (pt) 2001-12-28
AU2138995A (en) 1995-10-23
EP0752847A1 (en) 1997-01-15
NO964070L (no) 1996-11-28
US5710182A (en) 1998-01-20
RO115409B1 (ro) 2000-02-28
RU2139016C1 (ru) 1999-10-10
CZ290987B6 (cs) 2002-11-13
HUT75666A (en) 1997-05-28
DE752847T1 (de) 1997-09-04
CN1112918C (zh) 2003-07-02
JPH10503470A (ja) 1998-03-31
EP0752847B1 (en) 2001-07-11
HK1013953A1 (en) 1999-09-17
GR3036763T3 (en) 2001-12-31
BR9507438A (pt) 1997-09-16
MX9603918A (es) 1997-04-30
AU694497B2 (en) 1998-07-23
KR970702024A (ko) 1997-05-13
KR100365914B1 (ko) 2003-04-16
DE69521686D1 (de) 2001-08-16

Similar Documents

Publication Publication Date Title
DK0752847T3 (da) Ophthalmisk sammensætning med nedsat viskositet
SE9401109D0 (sv) Opthalmic composition II
US5945121A (en) Liposome eye drops
KR960700081A (ko) 콘택트렌즈 용액 보존 시스템(preservative system for contact lens solutions)
NZ230663A (en) Antimicrobial, hypotonic, aqueous contact lens composition
WO1998005365A3 (en) Compositions and methods for disinfecting contact lenses and preserving contact lens care products
NO940160D0 (no) Oeyepreparater inneholdende oxicam eller oxicamderivater
KR940006575A (ko) 증가된 안내압 치료를 위한 안구 국소 투여용 약제학적 조성물
DE60012068D1 (de) Zusammensetzung mit kontinuierlicher wässeriger Phase, die L-2-Oxothiazolidin- 4-carbonsäure enthält".
WO2009006130A2 (en) Salt free hyaluronate ophthalmic solution
JPS6452727A (en) Antiallergic eye drop
FI963744L (fi) Alennetun viskositeetin omaava oftalminen koostumus
AU2001242398A1 (en) Contact lens treating method and composition
JPS6217973B2 (cs)